Results 1 to 10 of about 94,278 (287)
Corneal Disease & Transplantation. [PDF]
J Clin Med, 2022 Corneal diseases represent the third leading cause of blindness worldwide, and corneal transplantation, which aims at restoring corneal clarity and vision, is the most frequently performed transplant worldwide [...]
Coco G, Romano V.
europepmc +6 more sources
Corneal Opacity in LCAT Disease [PDF]
Cornea, 1992 Deficiency of lecithin:cholesterol acyltransferase, LCAT disease, is one of the dyslipoproteinemias with characteristic lipid deposits in the cornea. The present report documents the clinicopathologic abnormalities of one case in which a full-thickness corneal specimen was obtained at the time of corneal transplantation.
David G. Cogan +3 more
openalex +5 more sources
Editorial: Corneal disease: an update. [PDF]
Front Med (Lausanne), 2023 Capasso L, De Bernardo M, Borrelli M.
europepmc +4 more sources
AN UNUSUAL CASE OF CORNEAL DISEASE [PDF]
British Journal of Ophthalmology, 1929 F. A. Williamson‐Noble
openalex +4 more sources
Keratoconus; a True Corneal Disease. [PDF]
J Ophthalmic Vis Res, 2016 Ghassembaglou N, Djalilian AR.
europepmc +4 more sources
Guidelines for the application of artificial intelligence in the diagnosis of anterior segment diseases (2023) [PDF]
International Journal of Ophthalmology, 2023 The landscape of ophthalmology has observed monumental shifts with the advent of artificial intelligence (AI) technologies. This article is devoted to elaborating on the nuanced application of AI in the diagnostic realm of anterior segment eye diseases ...
Yi Shao +6 more
doaj +1 more source
Corneal Cross-Linking: The Evolution of Treatment for Corneal Diseases [PDF]
Frontiers in Pharmacology, 2021 Corneal cross-linking (CXL) using riboflavin and ultraviolet A (UVA) light has become a useful treatment option for not only corneal ectasias, such as keratoconus, but also a number of other corneal diseases. Riboflavin is a photoactivated chromophore that plays an integral role in facilitating collagen crosslinking.
Duoduo Wu +16 more
openaire +4 more sources
HEREDITARY HEMORRHAGIC TELANGIECTASIA
Vision Pan-America, 2015 We describe a patient with clinical history of intermittent haemolacria associated to hereditary hemorrhagic telangiectasia, first seen and diagnosed by the ophthalmologist.
Messody Zagury +5 more
doaj +1 more source
Nanomedicine Approaches for Corneal Diseases [PDF]
Journal of Functional Biomaterials, 2015 Corneal diseases are the third leading cause of blindness globally. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antibiotics and tissue transplantation are currently used to treat corneal pathological conditions. However, barrier properties of the ocular surface necessitate high concentration of the drugs applied in the eye ...
Shyam Chaurasia +3 more
openaire +3 more sources
International Journal of Ophthalmology, 2013 AIM: To investigate the effects of bovine pituitary extract on the proliferation of keratocytes and maintaining the keratocyte phenotype in vitro.METHODS: Single keratocytes were isolated by enzyme digestion for in vitro culture.
Zhong-Zhong Xu +4 more
doaj +1 more source